Your session is about to expire
← Back to Search
Letrozole +/- Chemotherapy for Ovarian Cancer
Study Summary
This trial is testing whether Letrozole, with or without Paclitaxel and Carboplatin, can effectively treat patients with Stage II-IV Low-Grade Serous Carcinoma of the ovary, fallopian tube, or peritoneum.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 79 Patients • NCT02137538Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your creatinine levels are not too high, as checked within 14 days before enrolling in the study.I do not have any serious or uncontrolled infections, except for a simple UTI.I have another cancer, but it won't affect this trial's treatment.I am HIV positive, on treatment, and my viral load is undetectable.I have not had a heart attack or unstable heart pain in the last 6 months and do not have severe heart failure.I have been newly diagnosed with stage II-IV low-grade serous ovarian, fallopian tube, or primary peritoneal cancer.I have not had chemotherapy or radiotherapy before surgery for my condition.I had surgery to remove as much cancer as possible, with some cancer possibly left behind.I had serous borderline tumors before, but now have stage II-IV low-grade serous ovarian cancer.I have moderate to severe nerve damage.My ovarian cancer is low grade and has normal p53 according to my pathology report.I had surgery to remove cancer less than 8 weeks ago.My cancer shows normal p53 protein levels.Your liver enzymes (ALT and AST) are not more than 3 times the normal level.Your bilirubin levels are within a certain range, which will be checked within 14 days before joining the study.My cancer has spread to my brain.I have not had hormonal therapy for my condition.I can care for myself and am up and about more than 50% of my waking hours.I am 18 years old or older.I can take medications by mouth.I have had surgery to remove both ovaries and fallopian tubes.Your white blood cell count is at least 1500 per microliter.I am allergic to letrozole or have had bad reactions to carboplatin/paclitaxel.Your platelet count is 100,000 cells/microliter or more within 14 days before joining the study.
- Group 1: Arm I (paclitaxel, carboplatin, letrozole)
- Group 2: Arm II (letrozole)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the FDA-approved use for Letrozole?
"Letrozole is an effective palliative treatment for patients suffering from malignant esophageal neoplasms, peritoneal neoplasms, and other cancers."
Are there different facilities in the US that are participating in this research?
"To decrease the burden of travel, it is advised that patients enroll at the clinical trial site nearest to them. There are 100 locations enrolling patients in this study, which are situated in cities such as Denver, Goshen, and Norton Shores."
Has Letrozole been cleared by the FDA?
"There is both anecdotal and clinical evidence backing the safety of letrozole, thus it receives a score of 3."
How large is the study's test group?
"Yes, the trial is still recruiting patients. 450 participants are needed, and the study is being conducted at 100 sites."
Does Letrozole have a long history of efficacy in clinical trials?
"The National Institutes of Health Clinical Center first studied letrozole in 1995. As of now, there have been a total of 1732 completed trials with 1380 still active. Many of the ongoing trials are based in Denver, Colorado."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Average response time
- < 2 Days
Most responsive sites:
- PeaceHealth Saint Joseph Medical Center: < 48 hours
Typically responds via
Share this study with friends
Copy Link
Messenger